Ifrah Financial Services, Inc. Gilead Sciences, Inc. Transaction History

Ifrah Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $353,596 - $412,456	-5,450 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $2,476 - $3,019	-34 Reduced 0.62%	5,450 $411,000
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $92,708 - $108,826	-1,303 Reduced 19.2%	5,484 $393,000
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $489,410 - $580,084	6,787	6,787 $550,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ifrah Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Ifrah Financial Services, Inc. with notifications on news.